secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000950170-22-021575
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Geron Q3 net loss $41.1M; cash $195M; IMerge top-line results expected early Jan 2023
--------------------------------------------------------------------------------

- Net loss of $41.1M ($0.10/share) vs $26.7M ($0.08/share) in Q3 2021; revenues $0.3M.
- Cash and marketable securities $195M as of Sep 30, 2022; cash runway through mid-2024.
- Top-line results from IMerge Phase 3 trial in lower risk MDS expected in early January 2023.
- Class action lawsuit settlement for $24M (no admission of fault); court approval scheduled Q1 2023.
- FY 2022 GAAP operating expense guidance reaffirmed at $155M-$165M; headcount 98 employees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000095017022021575/0000950170-22-021575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000095017022021575/gern-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-021575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer